Clinical Trial Update: Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase III study evaluating DP-R206 and Bonvia for postmenopausal osteoporosis has completed; the update notes the status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonvia
• DP-R206

Snippet

Sponsor: Alvogen Korea | Conditions: Postmenopausal Women With Osteoporosis | Phase 3 | Status: COMPLETED